Skip to content
healthcare.dev

Rizatriptan

NDC 33342-088, Rizatriptan, tablet, film coated, from Macleods Pharmaceuticals Limited.

Product NDC
33342-088
Status
Listed
Labeler
Macleods Pharmaceuticals Limited
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA203147
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/33342-088 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • RIZATRIPTAN BENZOATE10 mg/1

Pharmacologic classes

Serotonin 1b Receptor Agonists [MoA]; Serotonin 1d Receptor Agonists [MoA]; Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]

Package NDCNDC-11Package
33342-088-073334200880730 TABLET, FILM COATED in 1 CONTAINER (33342-088-07)
33342-088-123334200881210 BLISTER PACK in 1 CARTON (33342-088-12) / 10 TABLET, FILM COATED in 1 BLISTER PACK
33342-088-41333420088413 BLISTER PACK in 1 CARTON (33342-088-41) / 6 TABLET, FILM COATED in 1 BLISTER PACK (33342-088-02)
33342-088-45333420088452 BLISTER PACK in 1 CARTON (33342-088-45) / 6 TABLET, FILM COATED in 1 BLISTER PACK (33342-088-02)
33342-088-4633342008846200 TABLET, FILM COATED in 1 CONTAINER (33342-088-46)
33342-088-50333420088504 BLISTER PACK in 1 CARTON (33342-088-50) / 3 TABLET, FILM COATED in 1 BLISTER PACK (33342-088-52)
33342-088-72333420088726 BLISTER PACK in 1 CARTON (33342-088-72) / 3 TABLET, FILM COATED in 1 BLISTER PACK (33342-088-52)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/27bc2cfc-fefb-4b50-a0dc-6268c69b4902
  • NADAC price for package 33342008841

    GET /v1/drugs/nadac/33342008841
  • NADAC price for package 33342008845

    GET /v1/drugs/nadac/33342008845

Use it

Look up 33342-088 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/33342-088 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 33342-088. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.